Literature DB >> 20020932

Determination of Bisphenol A (BPA) in Plasma of Hemodialysis Patients Using Three Methods: LC/ECD, LC/MS, and ELISA.

Junko Sajiki1, Yasuyuki Hasegawa, Hiroyuki Hashimoto, Yuuki Makabe, Fumio Miyamoto, Ryoko Yanagibori, Jeongsoo Shin, Yasushi Shimidzu, Tatsuya Morigami.   

Abstract

ABSTRACT Bisphenol A (BPA) values were compared in plasma of hemodialysis patients and in recycling solvents using LC/MS, LC/electrochemical detector (ECD), and enzyme linked immunosorbent assay (ELISA). BPA values in the plasma and the solvent were 0-8.4 ng/ml and 0-0.8 ng/ml for LC/ECD, 0-4.9 ng/ml and 0-0.8 ng/ml for LC/MS, and 0-15.5 ng/ml and 0-3.1 ng/ml for ELISA, respectively. There was no significant difference among BPA values both in the plasma and the solvents using three methods. Single correlation coefficients between LC/ECD and LC/MS, LC/ECD and ELISA, and LC/MS and ELISA were, respectively, 0.373 (p < 0.002), 0.347 (p < 0.002), and 0.945 (p < 0.001) in the plasma (n = 68-109) and 0.916 (p < 0.001), 0.431 (p > 0.05), and 0.332 (p > 0.05) in the solvents (n = 19). An unknown substance present in the plasma of patients but not healthy volunteers influenced the LC/ECD values of plasma repeated freezing and thawing. The results indicate that LC/MS and ELISA are appropriate for BPA analysis in plasma and both LC/MS and LC/ECD in the recycling solvents and handling with plasma before analysis is important to the analysis of BPA in patients' plasma using LC/ECD.

Entities:  

Year:  2008        PMID: 20020932     DOI: 10.1080/15376510802290900

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  2 in total

Review 1.  The adverse cardiac effects of Di(2-ethylhexyl)phthalate and Bisphenol A.

Authors:  Nikki Gillum Posnack
Journal:  Cardiovasc Toxicol       Date:  2014-12       Impact factor: 3.231

2.  A facile synthesis of nanostructured CoFe2O4 for the electrochemical sensing of bisphenol A.

Authors:  Qin Liu; Xiaozhi Kang; Lanzhi Xing; Zhixiang Ye; Yingchun Yang
Journal:  RSC Adv       Date:  2020-02-07       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.